- Home
- PDM vs TNDM Comparison
PDM vs TNDM Comparison
Compare PDM & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDM
- TNDM
- Stock Information
- Founded
- PDM 1997
- TNDM 2006
- Country
- PDM United States
- TNDM United States
- Employees
- PDM N/A
- TNDM N/A
- Industry
- PDM Building operators
- TNDM Medical/Dental Instruments
- Sector
- PDM Real Estate
- TNDM Health Care
- Exchange
- PDM Nasdaq
- TNDM Nasdaq
- Market Cap
- PDM 1.1B
- TNDM 1.1B
- IPO Year
- PDM N/A
- TNDM 2013
- Fundamental
- Price
- PDM $8.15
- TNDM $15.09
- Analyst Decision
- PDM Buy
- TNDM Buy
- Analyst Count
- PDM 5
- TNDM 17
- Target Price
- PDM $9.40
- TNDM $22.76
- AVG Volume (30 Days)
- PDM 839.1K
- TNDM 1.7M
- Earning Date
- PDM 10-27-2025
- TNDM 11-06-2025
- Dividend Yield
- PDM 3.08%
- TNDM N/A
- EPS Growth
- PDM N/A
- TNDM N/A
- EPS
- PDM N/A
- TNDM N/A
- Revenue
- PDM $565,372,000.00
- TNDM $1,001,719,000.00
- Revenue This Year
- PDM N/A
- TNDM $8.27
- Revenue Next Year
- PDM N/A
- TNDM $9.63
- P/E Ratio
- PDM N/A
- TNDM N/A
- Revenue Growth
- PDM N/A
- TNDM 25.84
- 52 Week Low
- PDM $5.46
- TNDM $9.98
- 52 Week High
- PDM $10.72
- TNDM $38.28
- Technical
- Relative Strength Index (RSI)
- PDM 41.50
- TNDM 57.20
- Support Level
- PDM $7.85
- TNDM $13.66
- Resistance Level
- PDM $8.90
- TNDM $15.43
- Average True Range (ATR)
- PDM 0.23
- TNDM 0.74
- MACD
- PDM -0.03
- TNDM -0.10
- Stochastic Oscillator
- PDM 24.29
- TNDM 68.14
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.